Brief: Molecure Signs Exclusive Licensing Deal With Ocean Biomedical
Oct 15 (Reuters) - Molecure SA MOCP.WA :
* SIGNS EXCLUSIVE LICENSING AGREEMENT WITH OCEAN BIOMEDICAL
* MAXIMUM VALUE OF PAYMENTS POSSIBLE TO OBTAIN IS $31.8
MILLION
* OCEAN GRANTED EXCLUSIVE RIGHTS TO DEVELOP AND
COMMERCIALIZE
OAT-3912
* TO RECEIVE $0.6 MILLION UPFRONT PAYMENT
* CONTRACT SEES SINGLE DIGIT GROWING PERCENTAGE BASED
REMUNERATION
FOR ROYALTIES FROM SALES OF NEW MEDICINE
Source text for Workspace: ID:nEM9K0YJVa
Further company coverage: MOCP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments